Moreover, significant differences in DNA methylation signatures between AML with DNMT3A-R882 and non-R882 mutations have been reported, suggesting that mutations in different DNMT3A domains lead to different neomorphic functions [31]. The gene discussed is DNMT3A; the disease is acute myeloid leukemia.